查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
歐洲下一代介入性心臟病學市場按產品類型、適應症類型、最終用戶和地區分類的分析和預測（2025 年至 2035 年）
市場調查報告書
商品編碼
1800746

歐洲下一代介入性心臟病學市場按產品類型、適應症類型、最終用戶和地區分類的分析和預測（2025 年至 2035 年）

Europe Next-Generation Intervention Cardiology Market: Focus on Product Type, Indication Type, End User, and Country - Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 87 Pages | 商品交期: 1-5個工作天內

價格

歐洲下一代介入性心臟病學市場規模預計將從 2024 年的 58.01 億美元成長到 2035 年的 130.63 億美元，在 2025-2035 年預測期內的複合年成長率為 7.66%。

新一代介入性心臟病學正在徹底改變歐洲的心臟護理，它採用先進的微創精準引導方法治療心臟瓣膜疾病、冠狀動脈疾病和結構性心臟缺陷。這個領域的一大特點是從傳統的開胸手術轉向更安全、更個人化的導管介入手術。歐洲醫生正在整合機器人技術、人工智慧影像處理和尖端設備技術，以提高手術的安全性、準確性和效率。除了改善患者預後和縮短復原時間外，這項發展還支持歐洲的醫療保健目標，即增加獲得最先進治療、最佳化醫院資源以及為老齡化人口提供高效的心血管解決方案。

主要市場統計數據
預測期 2025-2035
2025年評估 61.267億美元
2035年的預測 130.63億美元
複合年成長率 7.66%

市場介紹

隨著醫療保健系統優先考慮以患者為中心的微創解決方案來治療複雜的心血管疾病，歐洲新一代介入性心臟病學市場正經歷快速轉型。在歐洲，先進的導管介入手術正日益取代開胸手術，成為心血管疾病（包括冠狀動脈疾病、結構性心臟異常和瓣膜疾病）發病率和死亡率的主要原因。這項轉變源自於該地區致力於改善病患預後、減少住院時間和最佳化醫療資源。

新一代介入性心臟病學運用機器人技術、人工智慧影像處理、3D導航和先進的儀器技術，以提高手術的精確度、安全性和效率。歐洲各地的醫療機構正擴大採用藥物塗層球囊、生物可吸收支架、經導管主動脈瓣置換術(TAVR) 和經導管二尖瓣瓣膜修復(TMVR) 等創新技術。混合導管室和門診設施的建立進一步促進了這些最先進治療的廣泛應用，使患者更容易獲得這些療法。

包括歐盟醫療設備法規 (MDR) 在內的法律規範透過強制更高的安全標準和臨床檢驗來規範產品核准。加之醫療保健投資的不斷增加、人口老化以及醫療技術公司與學術機構之間強力的研發合作，歐洲已成為下一代介入性心臟病學技術創新和應用的關鍵樞紐。

市場區隔

第1部分：按產品類型

  • 機器人
    • 機器人輔助經皮冠狀動脈介入治療（R-PCI）
    • 機器人輔助冠狀動脈繞道手術手術（RA-CABG）
    • 機器人輔助二尖瓣置換術（RMVR）
    • 機器人輔助主動脈瓣置換術
  • 非機器人
    • IVUS
    • OCT
    • 其他干預措施
      • 支架
      • 導管
      • 導管導引線
      • PTCA球囊擴張術
      • 其他

第2部分：依適應症類型

  • 結構性心臟病
  • 冠狀動脈疾病
  • 心臟瓣膜疾病
  • 周邊動脈疾病
  • 先天性心臟疾病

第 3 部分：按最終用戶

  • 醫院和診所
  • 心臟中心
  • 門診手術中心

第4部分：按地區

  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他

歐洲下一代介入性心臟病學市場的趨勢、促進因素與挑戰

趨勢

  • 擴大採用下一代支架、球囊和導管的微創手術
  • 擴大經導管治療（TAVR、TMVR 等）作為開胸心臟外科手術的替代方案
  • 整合機器人和影像引導系統可提高準確性並減少併發症
  • 藥物塗層球囊、生物可吸收支架和新型支架材料的使用日益增多
  • 人工智慧、機器學習和 3D 影像在手術規劃和即時指導中的應用日益增多
  • 歐洲門診心臟護理中心和混合手術室成長強勁

驅動程式

  • 人口老化和生活方式導致的心血管疾病高發
  • 相較於傳統手術，對創傷更小、恢復更快的治療的需求日益成長
  • 歐洲醫療設備公司和研究機構支持的創新
  • 歐盟高階心臟護理醫療政策與報銷框架
  • 增加對數位醫療、遠距心臟病學和遠端患者監護的投資
  • 提高對冠狀動脈疾病和結構性心臟疾病的認知和早期診斷

任務

  • 下一代介入設備和機器人系統的高成本限制了區域准入。
  • 歐盟成員國報銷政策存在差異
  • 介入性心臟科醫師採用新技術的學習曲線和訓練要求
  • CE 標誌和歐盟 MDR 合規性的監管障礙導致產品上市延遲
  • 來自傳統療法和替代療法的競爭
  • 小型醫院混合導管室等基礎設施有限

產品/創新策略：本報告深入洞察歐洲下一代介入性心臟病學的最新技術進步，使公司能夠推動創新並開發滿足市場需求的尖端產品。

成長/行銷策略：透過提供全面的市場分析和識別關鍵的成長機會，公司能夠獲得制定有針對性的行銷策略和有效擴大其市場佔有率的知識。

競爭策略：報告包括全面的競爭格局分析，以了解歐洲下一代介入性心臟病學市場競爭對手的優勢和劣勢，並制定有效的策略以在市場上獲得競爭優勢。

監管與合規策略提供有關歐洲下一代介入心臟病學的法律規範、核准和行業指南的最新資訊，使公司能夠保持合規並加速新一代介入性心臟病學產品進入市場。

投資和業務擴大策略：透過分析市場趨勢、資金籌措模式和合作機會，我們幫助公司做出明智的投資決策並確定業務成長的潛在併購機會。

主要市場參與企業和競爭對手的摘要

公司簡介是根據從主要專家收集的意見以及對公司覆蓋範圍、產品系列和市場滲透率的分析而選擇的。

該市場的一些知名公司包括：

  • B. Braun SE
  • Koninklijke Philips NV
  • Siemens Healthineers AG

目錄

執行摘要

第1章：下一代介入性心臟病學市場：產業展望

  • 競爭格局
  • 下一代介入性心臟病學市場：診斷與管理
  • 冠狀動脈介入治療的進展
  • 冠狀動脈介入的未來方向和新興技術
  • 下一代介入性心臟病學市場的研發線產品
  • 監管狀況
    • 歐洲

第2章 市場動態

  • 趨勢
  • 市場動態

第3章下一代介入性心臟病學市場（按地區）價值，2024-2035 年

  • 區域摘要
  • 歐洲
    • 區域概況
    • 市場成長動力
    • 成長抑制因素
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 其他

第4章 競爭格局與公司概況

  • 公司簡介
    • Siemens Healthineers AG
    • Koninklijke Philips NV
    • B. Braun SE

第5章調查方法

Product Code: BHL3206SS

This report can be delivered in 2 working days.

Introduction to Europe Next-Generation Intervention Cardiology Market

The Europe next-generation intervention cardiology market is projected to reach $13,063.0 million by 2035 from $5,800.1 million in 2024, growing at a CAGR of 7.66% during the forecast period 2025-2035. Next-generation interventional cardiology is revolutionizing cardiac treatment in Europe by using sophisticated, minimally invasive, precision-guided methods to treat valvular diseases, coronary artery disease, and structural heart defects. There has been a noticeable change in the area from traditional open heart surgery to safer, more individualized catheter-based procedures. Robotics, AI-enhanced imaging, and cutting-edge device technologies are being integrated by European doctors to increase procedure safety, accuracy, and efficiency. In addition to improving patient outcomes and shortening recovery periods, this development supports Europe's healthcare aims of increasing access to cutting-edge therapies, optimizing hospital resources, and providing efficient cardiovascular solutions to an aging population.

KEY MARKET STATISTICS
Forecast Period2025 - 2035
2025 Evaluation$6,126.7 Million
2035 Forecast$13,063.0 Million
CAGR7.66%

Market Introduction

The Europe Next-Generation Interventional Cardiology Market is undergoing a rapid transformation as healthcare systems prioritize minimally invasive, patient-centric solutions for managing complex cardiovascular diseases. Advanced catheter-based operations are increasingly replacing open heart surgeries as the primary source of morbidity and mortality in Europe due to cardiovascular illnesses such coronary artery disease, structural heart abnormalities, and valvular disorders. The region's focus on enhancing patient outcomes, cutting hospital stays, and making the most of healthcare resources is what is causing this change.

Robotics, AI-powered imaging, 3D navigation, and advanced device technologies are all used in next-generation interventional cardiology to improve accuracy, safety, and procedural efficiency. Healthcare facilities throughout Europe are adopting innovations including drug-coated balloons, bioresorbable scaffolds, transcatheter aortic valve replacement (TAVR), and transcatheter mitral valve repair (TMVR) at an increasing rate. The spread of these cutting-edge therapies is further supported by the establishment of hybrid cath laboratories and ambulatory facilities, which provide greater accessibility for patients.

Regulatory frameworks, including the EU MDR (Medical Device Regulation), are shaping product approvals by enforcing higher safety standards and clinical validation. Coupled with rising healthcare investments, an aging population, and strong R&D collaborations between medtech companies and academic institutions, Europe is positioned as a key hub for next-generation interventional cardiology innovation and adoption.

Market Segmentation

Segmentation 1: By Product Type

  • Robotics
    • Robotic-Assisted Percutaneous Coronary Intervention (R-PCI)
    • Robotic-Assisted Coronary Artery Bypass Grafting (RA-CABG)
    • Robotic Assisted Mitral Valve-Replacement (RMVR)
    • Robotic Assisted Aortic Valve Replacement
  • Non-Robotics
    • IVUS
    • OCT
    • Other Interventions
      • Stents
      • Catheters
      • Guidewires
      • PTCA Balloons
      • Others

Segmentation 2: By Indication Type

  • Structural Heart Disease
  • Coronary Heart Diseases
  • Valvular Heart Diseases
  • Peripheral Artery Diseases
  • Congenital Heart Diseases

Segmentation 3: By End User

  • Hospitals and Clinics
  • Cardiac Centers
  • Ambulatory Surgical Centers

Segmentation 4: By Region

  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest-of-Europe

Europe Next-Generation Intervention Cardiology Market Trends, Drivers and Challenges

Trends

  • Growing adoption of minimally invasive procedures using next-gen stents, balloons, and catheters.
  • Expansion of transcatheter therapies (e.g., TAVR, TMVR) as alternatives to open-heart surgery.
  • Integration of robotics and image-guided systems to enhance precision and reduce complications.
  • Rising use of drug-coated balloons, bioresorbable scaffolds, and novel stent materials.
  • Increasing application of AI, machine learning, and 3D imaging in procedure planning and real-time guidance.
  • Strong growth in ambulatory cardiac care centers and hybrid operating rooms across Europe.

Drivers

  • High prevalence of cardiovascular diseases due to aging populations and lifestyle factors.
  • Growing demand for less invasive, faster-recovery treatments compared to conventional surgery.
  • Technological innovation supported by European medical device companies and research institutions.
  • Supportive EU healthcare policies and reimbursement frameworks for advanced cardiac interventions.
  • Rising investments in digital health, telecardiology, and remote patient monitoring.
  • Increasing awareness and early diagnosis of coronary and structural heart diseases.

Challenges

  • High cost of next-gen interventional devices and robotic systems limiting access in some regions.
  • Variability in reimbursement policies across EU member states.
  • Steep learning curve and training requirements for interventional cardiologists adopting new technologies.
  • Regulatory hurdles for CE marking and EU MDR compliance delaying product launches.
  • Competition from conventional procedures and alternative therapies.
  • Limited availability of infrastructure such as hybrid cath labs in smaller hospitals.

How can this report add value to an organization?

Product/Innovation Strategy: The report offers in-depth insights into the latest technological advancements in Europe next-generation intervention cardiology, enabling organizations to drive innovation and develop cutting-edge products tailored to market needs.

Growth/Marketing Strategy: By providing comprehensive market analysis and identifying key growth opportunities, the report equips organizations with the knowledge to craft targeted marketing strategies and expand their market presence effectively.

Competitive Strategy: The report includes a thorough competitive landscape analysis, helping organizations understand their competitors' strengths and weaknesses in Europe next-generation intervention cardiology and allowing them to strategize effectively to gain a competitive edge in the market.

Regulatory and Compliance Strategy: It provides updates on evolving regulatory frameworks, approvals, and industry guidelines specific to Europe next-generation intervention cardiology, ensuring organizations stay compliant and accelerate market entry for new next-generation intervention cardiology

Investment and Business Expansion Strategy: By analyzing market trends, funding patterns, and partnership opportunities, the report assists organizations in making informed investment decisions and identifying potential M&A opportunities for business growth.

Key Market Players and Competition Synopsis

Profiled companies have been selected based on inputs gathered from primary experts, as well as analyzing company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

  • B. Braun SE
  • Koninklijke Philips N.V.
  • Siemens Healthineers AG

Table of Contents

Executive Summary

Scope and Definition

1 Next-Generation Intervention Cardiology Market: Industry Outlook

  • 1.1 Competitive Landscape
    • 1.1.1 Business Strategies
      • 1.1.1.1 Product Developments in Next-Generation Intervention Cardiology Market
  • 1.2 Next-Generation Intervention Cardiology Market: Diagnosis and Management
  • 1.3 Advancements in Coronary Intervention
  • 1.4 Future Direction and Emerging Technologies in Coronary Interventions
  • 1.5 Pipeline Products in the Next-Generation Intervention Cardiology Market
  • 1.6 Regulatory Landscape
    • 1.6.1 Europe

2 Market Dynamics

  • 2.1 Trends
    • 2.1.1 Trends in the Next-Generation Intervention Cardiology Market
      • 2.1.1.1 Shift towards Minimally Invasive and Percutaneous Procedures Transforming Treatment Paradigms
      • 2.1.1.2 Integration of AI-Predictive Intelligence in Intervention Cardiology
        • 2.1.1.2.1 AI in Imaging, Lesion Assessment, and Diagnostics
  • 2.2 Market Dynamics
    • 2.2.1 Trends, Drivers, Challenges, and Opportunities: Current and Future Impact Assessment
    • 2.2.2 Market Drivers
      • 2.2.2.1 Rising Elderly Population, Driving Demand for Advanced Cardiac Interventions
        • 2.2.2.1.1 Cardiovascular Disease Burden in the Elderly
      • 2.2.2.2 Emergence of Robotic-Assisted Interventions- Enhancing Procedural Accuracy and Operator Control
    • 2.2.3 Market Restraints
      • 2.2.3.1 High Procedural Cost and Infrastructure Burden Limiting Broad Adoption
      • 2.2.3.2 Regulatory Complexity and Prolonged Approval Timelines Hindering Innovation
        • 2.2.3.2.1 Lengthy Approval Pathways for High-Risk Devices
        • 2.2.3.2.2 Lack of Harmonization across Geographies
        • 2.2.3.2.3 Regulatory Gaps for AI and Software-Driven Devices
    • 2.2.4 Market Opportunities
      • 2.2.4.1 Stent and Balloon Innovation Unlocking Next-Generation Use Cases
        • 2.2.4.1.1 Advancements in Drug-Coated Balloon Technologies
      • 2.2.4.2 Remote and Robotic-Enabled Expansion into Emerging Markets
        • 2.2.4.2.1 Bridging Access Gaps through Remote Robotics
    • 2.2.5 Market Challenges
      • 2.2.5.1 Data Standardization and Clinical Validation Gaps in AI-Driven Cardiology
      • 2.2.5.2 Safety and Clinical Validation Barriers for Next-Generation Vascular Implants

3 Next-Generation Intervention Cardiology Market (Region), Value ($million), 2024-2035

  • 3.1 Regional Summary
  • 3.2 Europe
    • 3.2.1 Regional Overview
    • 3.2.2 Driving Factors for Market Growth
    • 3.2.3 Factors Challenging the Market
    • 3.2.4 U.K.
    • 3.2.5 France
    • 3.2.6 Germany
    • 3.2.7 Italy
    • 3.2.8 Spain
    • 3.2.9 Rest-of-Europe

4 Competitive Landscape and Company Profiles

  • 4.1 Company Profiles
    • 4.1.1 Siemens Healthineers AG
      • 4.1.1.1 Overview
      • 4.1.1.2 Top Products/Product Portfolio
      • 4.1.1.3 Top Competitors
      • 4.1.1.4 Target Customers
      • 4.1.1.5 Strategic Positioning and Market Impact
      • 4.1.1.6 Analyst View
      • 4.1.1.7 Pipeline and Research Initiatives
    • 4.1.2 Koninklijke Philips N.V.
      • 4.1.2.1 Overview
      • 4.1.2.2 Top Products/Product Portfolio
      • 4.1.2.3 Top Competitors
      • 4.1.2.4 Target Customers
      • 4.1.2.5 Strategic Positioning and Market Impact
      • 4.1.2.6 Analyst View
      • 4.1.2.7 Pipeline and Research Initiatives
    • 4.1.3 B. Braun SE
      • 4.1.3.1 Overview
      • 4.1.3.2 Top Products/Product Portfolio
      • 4.1.3.3 Top Competitors
      • 4.1.3.4 Target Customers
      • 4.1.3.5 Strategic Positioning and Market Impact
      • 4.1.3.6 Analyst View
      • 4.1.3.7 Pipeline and Research Initiatives

5 Research Methodology

  • 5.1 Data Sources
    • 5.1.1 Primary Data Sources
    • 5.1.2 Secondary Data Sources
    • 5.1.3 Inclusion and Exclusion
    • 5.1.4 Data Triangulation
  • 5.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Europe Next-Generation Intervention Cardiology Market (by Scenario), $Million, 2024, 2028, and 2035
  • Figure 2: Europe Next-Generation Intervention Cardiology Market, 2024-2035
  • Figure 3: Europe Next-Generation Intervention Cardiology Market Snapshot
  • Figure 4: Next-Generation Intervention Cardiology Market, $Million, 2024 and 2035
  • Figure 5: Europe Next-Generation Intervention Cardiology Market (by Product Type), $Million, 2024, 2028, and 2035
  • Figure 6: Europe Next-Generation Intervention Cardiology Market (by Indication Type), $Million, 2024, 2028, and 2035
  • Figure 7: Europe Next-Generation Intervention Cardiology Market (by End User), $Million, 2024, 2028, and 2035
  • Figure 8: Next-Generation Intervention Cardiology Market Segmentation
  • Figure 9: Cardiovascular Disease Statistics
  • Figure 10: Inclusion and Exclusion Criteria for Europe Next-Generation Intervention Cardiology Market
  • Figure 11: Data Triangulation
  • Figure 12: Top-Down and Bottom-Up Approach
  • Figure 13: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Pipeline Products in Next-Generation Intervention Cardiology Market
  • Table 3: Next-Generation Intervention Cardiology Market (by Region), $Million, 2024-2035
  • Table 4: Europe Next-Generation Intervention Cardiology Market (by Product Type), $Million, 2024-2035
  • Table 5: Europe Next-Generation Intervention Cardiology Market (by Robotics), $Million, 2024-2035
  • Table 6: Europe Next-Generation Intervention Cardiology Market (by Non-Robotics), $Million, 2024-2035
  • Table 7: Europe Next-Generation Intervention Cardiology Market (by Other Interventions), $Million, 2024-2035
  • Table 8: Europe Next-Generation Intervention Cardiology Market (by Stents Type), $Million, 2024-2035
  • Table 9: Europe Next-Generation Intervention Cardiology Market (by Indication Type), $Million, 2024-2035
  • Table 10: Europe Next-Generation Intervention Cardiology Market (by End User), $Million, 2024-2035
  • Table 11: U.K. Next-Generation Intervention Cardiology Market (by Product Type), $Million, 2024-2035
  • Table 12: U.K. Next-Generation Intervention Cardiology Market (by Robotics), $Million, 2024-2035
  • Table 13: U.K. Next-Generation Intervention Cardiology Market (by Non-Robotics), $Million, 2024-2035
  • Table 14: U.K. Next-Generation Intervention Cardiology Market (by Other Interventions), $Million, 2024-2035
  • Table 15: U.K. Next-Generation Intervention Cardiology Market (by Stents Type), $Million, 2024-2035
  • Table 16: U.K. Next-Generation Intervention Cardiology Market (by Indication Type), $Million, 2024-2035
  • Table 17: U.K. Next-Generation Intervention Cardiology Market (by End User), $Million, 2024-2035
  • Table 18: France Next-Generation Intervention Cardiology Market (by Product Type), $Million, 2024-2035
  • Table 19: France Next-Generation Intervention Cardiology Market (by Robotics), $Million, 2024-2035
  • Table 20: France Next-Generation Intervention Cardiology Market (by Non-Robotics), $Million, 2024-2035
  • Table 21: France Next-Generation Intervention Cardiology Market (by Other Interventions), $Million, 2024-2035
  • Table 22: France Next-Generation Intervention Cardiology Market (by Stents Type), $Million, 2024-2035
  • Table 23: France Next-Generation Intervention Cardiology Market (by Indication Type), $Million, 2024-2035
  • Table 24: France Next-Generation Intervention Cardiology Market (by End User), $Million, 2024-2035
  • Table 25: Germany Next-Generation Intervention Cardiology Market (by Product Type), $Million, 2024-2035
  • Table 26: Germany Next-Generation Intervention Cardiology Market (by Robotics), $Million, 2024-2035
  • Table 27: Germany Next-Generation Intervention Cardiology Market (by Non-Robotics), $Million, 2024-2035
  • Table 28: Germany Next-Generation Intervention Cardiology Market (by Other Interventions), $Million, 2024-2035
  • Table 29: Germany Next-Generation Intervention Cardiology Market (by Stents Type), $Million, 2024-2035
  • Table 30: Germany Next-Generation Intervention Cardiology Market (by Indication Type), $Million, 2024-2035
  • Table 31: Germany Next-Generation Intervention Cardiology Market (by End User), $Million, 2024-2035
  • Table 32: Italy Next-Generation Intervention Cardiology Market (by Product Type), $Million, 2024-2035
  • Table 33: Italy Next-Generation Intervention Cardiology Market (by Robotics), $Million, 2024-2035
  • Table 34: Italy Next-Generation Intervention Cardiology Market (by Non-Robotics), $Million, 2024-2035
  • Table 35: Italy Next-Generation Intervention Cardiology Market (by Other Interventions), $Million, 2024-2035
  • Table 36: Italy Next-Generation Intervention Cardiology Market (by Stents Type), $Million, 2024-2035
  • Table 37: Italy Next-Generation Intervention Cardiology Market (by Indication Type), $Million, 2024-2035
  • Table 38: Italy Next-Generation Intervention Cardiology Market (by End User), $Million, 2024-2035
  • Table 39: Spain Next-Generation Intervention Cardiology Market (by Product Type), $Million, 2024-2035
  • Table 40: Spain Next-Generation Intervention Cardiology Market (by Robotics), $Million, 2024-2035
  • Table 41: Spain Next-Generation Intervention Cardiology Market (by Non-Robotics), $Million, 2024-2035
  • Table 42: Spain Next-Generation Intervention Cardiology Market (by Other Interventions), $Million, 2024-2035
  • Table 43: Spain Next-Generation Intervention Cardiology Market (by Stents Type), $Million, 2024-2035
  • Table 44: Spain Next-Generation Intervention Cardiology Market (by Indication Type), $Million, 2024-2035
  • Table 45: Spain Next-Generation Intervention Cardiology Market (by End User), $Million, 2024-2035
  • Table 46: Rest-of-Europe Next-Generation Intervention Cardiology Market (by Product Type), $Million, 2024-2035
  • Table 47: Rest-of-Europe Next-Generation Intervention Cardiology Market (by Robotics), $Million, 2024-2035
  • Table 48: Rest-of-Europe Next-Generation Intervention Cardiology Market (by Non-Robotics), $Million, 2024-2035
  • Table 49: Rest-of-Europe Next-Generation Intervention Cardiology Market (by Other Interventions), $Million, 2024-2035
  • Table 50: Rest-of-Europe Next-Generation Intervention Cardiology Market (by Stents Type), $Million, 2024-2035
  • Table 51: Rest-of-Europe Next-Generation Intervention Cardiology Market (by Indication Type), $Million, 2024-2035
  • Table 52: Rest-of-Europe Next-Generation Intervention Cardiology Market (by End User), $Million, 2024-2035